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Ab s t r a c t
The abnormal misfolded isoform of prion protein (PrPd; “d” for disease) is considered as a surrogate marker for infec-
tivity in the transmissible spongiform encephalopathies (TSEs) or prion diseases, including Creutzfeldt-Jakob disease
(CJD). In this experiment, we used intraocular inoculation to study PrPd deposition in the visual system of the brain
of mice infected with the Fujisaki (K.Fu) strain of Gerstmann-Sträussler-Scheinker (GSS) disease. We report here that
PrPd is deposited in the superior colliculus following contralateral intraocular inoculation and thus follows neuronal
connections when it spreads into the brain. Until 26 weeks postinoculation, no PrPd-specific immunostaining was observed
in the brain. At 27 weeks postinoculation, PrPd targeted to the contralateral superior colliculus as delicate granular
synaptic deposits located in the superficial part of this structure. As already reported, a few spongiform vacuoles were
visible in the same area by conventional H&E staining. In several other sections, vacuoles were visible but no PrPd stain-
ing could be detected.
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Introduction
The abnormal misfolded isoform of prion protein
(PrPd; “d” for disease) is considered as a surrogate mar-
ker for infectivity in the transmissible spongiform ence-
 phalopathies (TSEs) or prion diseases [30], including
Creutzfeldt-Jakob disease (CJD) [3,6,31]. In this exper-
iment, we used intraocular inoculation to study PrPd
deposition in the visual system of the brain of mice
infected with the Fujisaki (K.Fu) strain of Gerstmann-
Sträussler-Scheinker (GSS) disease. We report here that
PrPd is deposited in the superior colliculus following con-
tralateral intraocular inoculation and thus follows neu-
ronal connections when it spreads into the brain [32].
Material and methods
The experiment was designed to recapitulate that
of targeting scrapie pathology to the contralateral supe-
rior colliculus following intraocular injection [32]. To this
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end, four- to five-week-old NIH Swiss mice of both sex-
es were inoculated into the right anterior eye cham-
ber with 0.01 mL of a 10% (w/v) clarified brain sus-
pension of the Fujisaki strain of GSS [33,34]. Brains were
collected beginning at 18 weeks postinoculation and
the experiment was terminated when unequivocal
Fig. 1. Low (A) and high (B) magnification of ex -
pression of PrP (arrows) in superior colliculus 27th
week postinoculation.
Fig. 2. The same region stained with H&E. 
A
B
spongiform changes appeared in the contralateral supe-
rior colliculus. The latter part of the experiment has
been already published [32]. Two mice were sacrificed
weekly by decapitation under light anaesthesia with
ketamine and brains were immediately fixed in 10%
buffered formalin. Brains were then transected coro-
nally to include the mesencephalon with superior col-
liculi and lateral geniculate bodies. For immunohisto-
chemistry, paraffin-embedded sections were immersed
in 100% formic acid for 15 minutes, then equilibrated
in digestion buffer (50 mM TRIS-HCL, 1 mM ethylen -
ediaminetetraacetic acid, 0.1% Tween 20, pH 7.8) for
5 minutes and treated with proteinase K (1  µg/mL in
digestion buffer) for 15 minutes at 37°C followed by 
autoclaving in distilled water for 15 minutes (121°C) in
a pressure cooker. We used the 6H4 monoclonal anti-
PrP antibody (Prionics, Zurich) or 3F4 antibody (DAKO)
and the ABC technique with the Vectastatin Elite ABC-
kit, using DAB as chromogen as previously described [27]. 
Results
Until 26 weeks postinoculation, no PrPd-speci-
fic immunostaining was observed in the brain. At 
27 weeks postinoculation, PrPd targeted to the con-
tralateral superior colliculus as delicate granular sy naptic
deposits located in the superficial part of this struc-
ture (Fig. 1A-B). As already reported [32] (Fig. 2), a few
spongiform vacuoles were visible in the same area by
conventional H&E staining. In several other sections,
vacuoles were visible but no PrPd staining could be
detected.
Discussion
The involvement of the visual system is well
recognised in prion diseases. First, if scrapie is inocu-
lated intraocularly, infection travels along the optic
nerves to target the superior colliculi and lateral genic-
ulate bodies [16-18,24,25,32,37-40]. Second, scrapie repli-
cates in the eye [11,23] and PrPd is expressed in the reti-
na [12] and its mRNA is detected in the optic tectum
[19]. In variant CJD, PrPd is expressed in the retina and
the proximal part of the optic nerve at levels of 2.5%
and 25% of the brain concentration, respectively
[20,43]. Third, the retina degenerates in several mod-
els of scrapie and CJD in rodents as a result of apop-
tosis of ganglion cells [7-10,14,15,21,23], and cases of
CJD and GSS with retinal or geniculate body degen-
eration or optic nerve atrophy have already been report-
ed [1,2,26,29,36,41,42]. Of note, in a GSS case with bila -
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teral optic atrophy, the retina was normal [41]. Fourth,
iatrogenic CJD cases following corneal transplantation
have been described [4]. 
Here, we report that following intraocular inocula-
tion, both spongiform change and PrP deposition tar-
geted the superior colliculus as it has been showed by
classical neuropathologic methods [32]. This targeting
of PrP to the superior colliculus showed that PrPd and
spongiform change follow structured neural pathways
of the visual system of the brain, as already suggest-
ed in studies on the spread of infectivity from the
periphery to the central nervous system [32]. Of note,
spongiform change in the superior colliculus was not
always accompanied by PrP deposition, and this dis-
crepancy has also been noticed, albeit infrequently, by
other investigators [28]. Alterations in the glycosyla-
tion pattern have been studied following inoculation
into the superior colliculus in two models (the ME7 and
the 139A) of scrapie in rodents [35]. The non-glycosy-
lated PrP band increased first in the retina and then
in the optic nerves while the deglycosylated band
decreased concomitantly. Thus, alterations of the gly-
cosylation pattern follows the structure of the optic
pathways – these changes appear first in the cell bod-
ies and then in their respective axons. These data, along
with our immunohistochemical studies, strongly sug-
gest spreading of infectivity and its surrogate marker
PrPd through connections of the visual system via fast
axonal transport [5]. Indeed, the mutation at the first
glycosylation site results in the accumulation of PrPd
within the cell bodies [13].
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